Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surveillance and Control of Chronic Hepatitis C with Peginterferon and Ribavirin
NCT01195181Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Sep 2005
- Primary completion
- Dec 2009
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, peginterferon alfa-2b in hepatitis C (HCV), sponsored by Azienda Ospedaliero-Universitaria di Padova. Started Sep 2005; status: completed.
02
Drugs
peginterferon alfa-2apeginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01195181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195181.